JP2015034182A5 - - Google Patents

Download PDF

Info

Publication number
JP2015034182A5
JP2015034182A5 JP2014232639A JP2014232639A JP2015034182A5 JP 2015034182 A5 JP2015034182 A5 JP 2015034182A5 JP 2014232639 A JP2014232639 A JP 2014232639A JP 2014232639 A JP2014232639 A JP 2014232639A JP 2015034182 A5 JP2015034182 A5 JP 2015034182A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
integer
mol
polyorthoester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014232639A
Other languages
English (en)
Japanese (ja)
Other versions
JP6057972B2 (ja
JP2015034182A (ja
Filing date
Publication date
Priority claimed from US10/953,841 external-priority patent/US20050042194A1/en
Application filed filed Critical
Publication of JP2015034182A publication Critical patent/JP2015034182A/ja
Publication of JP2015034182A5 publication Critical patent/JP2015034182A5/ja
Application granted granted Critical
Publication of JP6057972B2 publication Critical patent/JP6057972B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2014232639A 2004-09-28 2014-11-17 半固体送達賦形剤および薬学的組成物 Expired - Lifetime JP6057972B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/953,841 US20050042194A1 (en) 2000-05-11 2004-09-28 Semi-solid delivery vehicle and pharmaceutical compositions
US10/953,841 2004-09-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012045876A Division JP2012107064A (ja) 2004-09-28 2012-03-01 半固体送達賦形剤および薬学的組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016203588A Division JP2017008113A (ja) 2004-09-28 2016-10-17 半固体送達賦形剤および薬学的組成物

Publications (3)

Publication Number Publication Date
JP2015034182A JP2015034182A (ja) 2015-02-19
JP2015034182A5 true JP2015034182A5 (enExample) 2015-04-09
JP6057972B2 JP6057972B2 (ja) 2017-01-11

Family

ID=36119607

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007533786A Withdrawn JP2008514646A (ja) 2004-09-28 2005-09-27 半固体送達賦形剤および薬学的組成物
JP2012045876A Withdrawn JP2012107064A (ja) 2004-09-28 2012-03-01 半固体送達賦形剤および薬学的組成物
JP2014232639A Expired - Lifetime JP6057972B2 (ja) 2004-09-28 2014-11-17 半固体送達賦形剤および薬学的組成物
JP2016203588A Pending JP2017008113A (ja) 2004-09-28 2016-10-17 半固体送達賦形剤および薬学的組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2007533786A Withdrawn JP2008514646A (ja) 2004-09-28 2005-09-27 半固体送達賦形剤および薬学的組成物
JP2012045876A Withdrawn JP2012107064A (ja) 2004-09-28 2012-03-01 半固体送達賦形剤および薬学的組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016203588A Pending JP2017008113A (ja) 2004-09-28 2016-10-17 半固体送達賦形剤および薬学的組成物

Country Status (10)

Country Link
US (10) US20050042194A1 (enExample)
EP (4) EP2902012B1 (enExample)
JP (4) JP2008514646A (enExample)
KR (1) KR20070083851A (enExample)
CN (1) CN101052376A (enExample)
AU (1) AU2005289425A1 (enExample)
CA (1) CA2579297A1 (enExample)
ES (1) ES2529574T3 (enExample)
TW (1) TWI407966B (enExample)
WO (1) WO2006037116A2 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050042194A1 (en) * 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2959893A1 (en) 2002-12-13 2015-12-30 DURECT Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
CA2581287C (en) * 2004-09-17 2015-08-25 Durect Corporation Sustained local anesthetic composition containing bupivacaine and saib
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US20070264339A1 (en) * 2006-05-12 2007-11-15 Ap Pharma, Inc. Base-stabilized polyorthoester formulations
US20070264338A1 (en) * 2006-05-12 2007-11-15 Shah Devang T Base-stabilized polyorthoester formulations
US20070265329A1 (en) * 2006-05-12 2007-11-15 Devang Shah T Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
FR2901702A1 (fr) * 2006-05-31 2007-12-07 Galderma Res & Dev S N C Snc Utilisation de granisetron pour le traitement de sous-types de la rosacee, et compositions pharmaceutiques
US7875697B2 (en) * 2006-06-29 2011-01-25 Medtronic, Inc. Poly(orthoester) polymers, and methods of making and using same
EP1917971A1 (en) * 2006-10-27 2008-05-07 Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) Substained release formulations comprising very low molecular weight polymers
EP2117521B1 (en) 2006-11-03 2012-06-27 Durect Corporation Transdermal delivery systems comprising bupivacaine
WO2009088414A2 (en) 2007-12-06 2009-07-16 Durect Corporation Oral pharmaceutical dosage forms
US8940315B2 (en) * 2008-04-18 2015-01-27 Medtronic, Inc. Benzodiazepine formulation in a polyorthoester carrier
US8956642B2 (en) * 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
JP2011518881A (ja) * 2008-04-28 2011-06-30 ゾゲニクス インコーポレーティッド 片頭痛の治療のための製剤
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
MX2011000629A (es) * 2008-07-17 2011-04-26 Merial Ltd Formulaciones analgesicas inyectables de larga duracion para animales.
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
TWI372057B (en) * 2008-12-11 2012-09-11 Dev Center Biotechnology Sustained release implant for granisetron
BRPI0922189A2 (pt) * 2008-12-11 2018-10-23 A P Pharma Inc "métodos para aumentar a estabilidade de poliortoésteres e suas formulações".
US9849180B2 (en) * 2014-09-15 2017-12-26 Hui Rong Shen Long-acting semi-solid lipid formulations
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
CN111956598A (zh) * 2013-03-15 2020-11-20 赫伦治疗有限公司 聚原酸酯和质子惰性溶剂的组合物
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US20140323517A1 (en) * 2013-04-30 2014-10-30 Heron Therapeutics, Inc. Compositions and methods for injection of a biodegradable polymer-based delivery system
EP3054932B1 (en) 2013-10-07 2020-12-09 Teikoku Pharma USA, Inc. Dexmedetomidine transdermal delivery devices and methods for using the same
BR112016006848A2 (pt) 2013-10-07 2017-08-01 Teikoku Pharma Usa Inc métodos e composições para distribuição transdérmica de uma quantidade não sedativa de dexmedetomidina
TWI709417B (zh) 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
US9801945B2 (en) 2014-04-21 2017-10-31 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
JP6723162B2 (ja) * 2014-04-21 2020-07-15 ヘロン セラピューティクス， インコーポレイテッドＨｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． ポリオルトエステルおよび有機酸添加剤の組成物
WO2018048460A1 (en) 2014-04-21 2018-03-15 Heron Therapeutics, Inc. A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam
SI3134068T1 (sl) * 2014-04-21 2021-11-30 Heron Therapeutics, Inc. Polimerni dovajalni sistemi z dolgotrajnim delovanjem
KR102413459B1 (ko) 2016-07-06 2022-06-24 듀렉트 코퍼레이션 약물 조성물, 장벽 층 및 약물 층을 갖는 경구 투여 형태
CN107789628B (zh) * 2016-12-29 2021-07-23 天津键凯科技有限公司 一种聚乙二醇和局部麻醉药的结合物在非麻醉镇痛中的应用
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US11162850B2 (en) 2019-04-25 2021-11-02 Measurement Specialties, Inc. Sensor assemblies with integrated electrical connections and diaphragm overload protection
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
CN114886840B (zh) * 2020-07-10 2023-08-25 南京海鲸药业股份有限公司 一种具有酸敏感降解、温敏性质的系列聚合物及其载药组合物
EP4277702A1 (en) 2021-01-12 2023-11-22 Durect Corporation Sustained release drug delivery systems and related methods
JP2024534963A (ja) * 2021-09-09 2024-09-26 ゼリス ファーマシューティカルズ インコーポレイテッド 注射可能な高濃度の薬学的製剤ならびにその製造および使用の方法
CN114366711A (zh) * 2021-12-09 2022-04-19 安徽大学 原酸酯混溶物药用辅料、制备方法、包含该辅料的局部缓释给药制剂
WO2023137659A1 (zh) * 2022-01-20 2023-07-27 南京泛太化工医药研究所 一种具有酸敏感降解、温敏性质的系列聚合物及其载药组合物

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179497A (en) * 1973-12-17 1979-12-18 Merck & Co., Inc. Solid state ophthalmic medication
US4131648A (en) * 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4180646A (en) * 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4098709A (en) * 1975-12-11 1978-07-04 Rohm And Haas Company Polymeric antioxidant viscosity index improvers
US4079038A (en) * 1976-03-05 1978-03-14 Alza Corporation Poly(carbonates)
US4304767A (en) * 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US4322323A (en) * 1980-12-01 1982-03-30 Alza Corporation Erodible device comprising surfactant for modifying the rate of erosion of the device
PT75625B (en) 1981-10-08 1985-12-09 Merck & Co Inc Process for preparing biosoluble ocular insert
US4532335A (en) * 1983-03-07 1985-07-30 Sri International Preparation of ketene acetals by rearrangement of allyl and substituted allyl acetals
GB8416234D0 (en) * 1984-06-26 1984-08-01 Ici Plc Biodegradable amphipathic copolymers
US4549010A (en) * 1984-06-27 1985-10-22 Merck & Co., Inc. Bioerodible poly(ortho ester) thermoplastic elastomer from diketene diacetal
US4946931A (en) * 1989-06-14 1990-08-07 Pharmaceutical Delivery Systems, Inc. Polymers containing carboxy-ortho ester and ortho ester linkages
HU218654B (hu) * 1989-11-28 2000-10-28 Syntex (U.S.A.) Inc. Triciklusos vegyületek, ezeket hatóanyagként tartalmazó gyógyászati készítmények és eljárás előállításukra
NZ239370A (en) 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
MX9200038A (es) 1991-01-09 1992-11-01 Alza Corp Dispositivos biodegradables y composiciones para la liberacion por difusion de agentes.
US5929059A (en) * 1991-01-19 1999-07-27 Smithkline Beecham P.L.C. Pharmaceutical compositions containing granisetron and dexamethasone
US5211951A (en) * 1991-07-24 1993-05-18 Merck & Co., Inc. Process for the manufacture of bioerodible poly (orthoester)s and polyacetals
EP0633907A1 (en) 1992-03-30 1995-01-18 Alza Corporation Additives for bioerodible polymers to regulate degradation
US5540912A (en) * 1992-03-30 1996-07-30 Alza Corporation Viscous suspensions of controlled-release drug particles
AU4406793A (en) * 1992-06-04 1993-12-30 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
US5922340A (en) * 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
MY113268A (en) * 1992-12-29 2002-01-31 Insite Vision Incorporated Plasticized bioerodible controlled delivery system
CA2153063A1 (en) 1992-12-29 1994-07-07 Lyle M. Bowman Bioerodible controlled delivery system
CA2187353C (en) * 1994-04-08 2007-05-22 Gerald L. Yewey Liquid delivery compositions
GB9412995D0 (en) * 1994-06-28 1994-10-26 Prendergast Kenneth F Safety enhancing pharmaceutical compositions of an active indazole
US6007845A (en) 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US5607686A (en) * 1994-11-22 1997-03-04 United States Surgical Corporation Polymeric composition
US5968543A (en) * 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
ATE197310T1 (de) 1996-01-05 2000-11-15 Advanced Polymer Systems Inc Polymere mit kontrolliertem physikalischen zustand und bioerodierbarkeit
US5690059A (en) * 1996-04-16 1997-11-25 Woods; Jeff Training collar
FR2748364B1 (fr) * 1996-05-09 1998-07-31 Kuhn Sa Broyeur de vegetaux perfectionne quant a sa faculte d'adaptation au relief du sol
NZ332777A (en) 1996-06-21 2000-06-23 Merck Sharp & Dohme 3,6-bi-phenyl substituted spiro-piperidine derivatives
US6046187A (en) * 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
ES2221019T3 (es) * 1996-10-31 2004-12-16 Takeda Chemical Industries, Ltd. Preparacion de liberacion mantenida.
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
WO1998053815A1 (en) 1997-05-30 1998-12-03 Minnesota Mining And Manufacturing Company Transdermal drug delivery device for the delivery of tropisetron or granisetron
US6103266A (en) * 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
US5939453A (en) 1998-06-04 1999-08-17 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
GB9813576D0 (en) 1998-06-24 1998-08-19 Merck Sharp & Dohme Therapeutic agents
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
CA2445638C (en) * 2000-05-11 2010-02-09 Advanced Polymer Systems, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US6613355B2 (en) * 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US20050042194A1 (en) * 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
EP1303527B1 (en) 2000-07-18 2004-09-29 Leo Pharma A/S Matrix metalloproteinase inhibitors
KR100446101B1 (ko) * 2000-12-07 2004-08-30 주식회사 삼양사 수난용성 약물의 서방성 제형 조성물
US6590059B2 (en) * 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
US20020176844A1 (en) * 2001-05-11 2002-11-28 Ng Steven Y. Bioerodible polyorthoesters containing hydrogen bonding groups
FR2826280B1 (fr) * 2001-06-20 2005-03-04 Ceva Sante Animale Composition semi-solide injectable biodegradable assurant un profil de liberation particulier
US6524606B1 (en) * 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
IL166418A0 (en) * 2002-07-31 2006-01-15 Alza Corp Injectable depot compositions and uses thereof
EP2030611A1 (en) * 2002-07-31 2009-03-04 Alza Corporation Injectable multimodal polymer depot compositions and uses thereof
WO2004043432A2 (en) * 2002-11-06 2004-05-27 Alza Corporation Controlled release depot formulations
US7045589B2 (en) * 2002-11-15 2006-05-16 A.P. Pharma, Inc. Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
US20050096365A1 (en) * 2003-11-03 2005-05-05 David Fikstad Pharmaceutical compositions with synchronized solubilizer release
AU2006230247A1 (en) * 2005-03-31 2006-10-05 A.P. Pharma, Inc. PEG-polyacetal and PEG-polyacetal-POE graft copolymers and pharmaceutical compositions
JP2008537757A (ja) * 2005-03-31 2008-09-25 エーピー ファーマ， インコーポレイテッド Ｐｅｇ−ポリ（オルトエステル）グラフトコポリマーおよび医薬組成物
US20070264339A1 (en) 2006-05-12 2007-11-15 Ap Pharma, Inc. Base-stabilized polyorthoester formulations

Similar Documents

Publication Publication Date Title
JP2015034182A5 (enExample)
JP2015522001A5 (enExample)
JP2016516062A5 (enExample)
NZ628828A (en) Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease
RU2015117539A (ru) Диагностика, профилактика и лечение болезней суставов
JP2019501133A5 (enExample)
JP2017039758A (ja) 生分解性薬物送達組成物
US11844837B2 (en) Compositions of a polyorthoester and an organic acid excipient
JP2015520184A5 (enExample)
IN2012DN00407A (enExample)
AR058866A1 (es) Un polimero biocompatible, no biodegradable, no toxico, util para composiciones farmaceuticas en nanoparticulas
RU2016139373A (ru) Растворы бупренорфина с замедленным высвобождением
JP2016531895A5 (enExample)
SA517381298B1 (ar) تركيبة صيدلية بثبات محسن
JP2014518272A5 (enExample)
JP2019537589A5 (enExample)
JP2016530316A5 (enExample)
RU2015102810A (ru) Функционализированные липосомы, пригодные для доставки биоактивных соединений
JP2012503602A5 (enExample)
ES2813856T3 (es) Solución antiinfecciosa que comprende un compuesto pirido(3,2,1-ij-benzoxadiazina
US20170049699A1 (en) Fluoropolymer Emulsions with Branched Semifluorinated Block Copolymer or Phospholipid Surfactant for the Delivery of Hydrophobic Drugs
JP2007515425A (ja) 医薬組成物
US20170100336A1 (en) Fluoropolymer Emulsions with Perhalogenated Stabilizer for the Delivery of Hydrophobic Drugs
JP5936099B2 (ja) 電解コンデンサ用電解液
CN112300099A (zh) 药物的缩酮衍生物及其制备方法、药物组合物和用途